Even as India reaches the halfway point in the 21-day lockdown, there isn’t much positive news in terms of a drop in cases and most experts reckon the lockdown will be extended beyond April 15. Indian startups have continued to take charge of the situation with new services and products and through partnerships. Healthcare startups have taken the front seat, and besides ensuring seamless service to its users, these startups are working with several governments to help them in whatever way they can! Many have already agreed that the pandemic will change the landscape across industries.
In the last three #AskMeAnything hosted as part of #StartupsVsCovid19 sessions had the opportunity to discuss the impact of Covid-19 on the businesses and the measures taken by the startup ecosystem stakeholders to sustain themselves through the storm or support others.
In our previous sessions, we had an agenda to encourage best possible practices for a business in such times. We got — Siddarth Pai, founding partner, 3one4 Capital who talked about the investment outlook in 2020; Ashish Tulsian, Cofounder & CEO, POSist who shared insights on reprioritization of business needs for startup; and Dhruvil Sanghvi, CEO, LogiNext who discussed alternatives to the current supply chain model.
The next edition, we are happy to introduce our fourth guest for the series — Prashant Tandon, Co-Founder & CEO of 1mg.
About The Session
We will be talking to Prashant about the surge in the demand for an online healthcare marketplace and what new avenues might open up once the lockdown ends. Prashant will be addressing the challenges, upcoming trends in the healthcare industry and his experiences of running a healthtech startup while being quarantined.
The session will cover:
- The New Fundraising Environment In India’s Healthtech Industry
- The Emerging Policies and Regulatory Environment
- Identifying The Shifts In Consumer Behaviour
- Solving For The Next Billion Users By Leveraging Healthtech
- Future Of India’s Healthtech Market
Prashant started the 1mg app in 2015. The digital healthcare platform currently holds ~35% share of category amongst medical apps with over 350 Mn Monthly PageViews. So far, the company has raised $170 Mn in funding from investors including — Sequoia Capital, Maverick Ventures, HBM Healthcare Investments, Omidyar Network.